Browse/search for people

Dr Daisy Elliott


Daisy is currently based at NIHR Bristol Biomedical Research Centre and Bristol Centre for Surgical Research, which aims to improve the surgical evidence base and patient care through high quality multidisciplinary research. She is also a member of the QuinteT group, which uses qualitative research methods to optimise recruitment and informed consent to randomised controlled trials (RCTs). 

Currently, Daisy co-leads the Surgical Innovation workstream on ‘Informed consent for new and evolving surgeries’. Within this, the team are using qualitative methods to understand how new surgical procedures are introduced and discussed with patients. She is also working on a number of surgical RCTs, including PART (comparing Partial Ablation versus Radical Treatment in intermediate risk, unilateral clinically localised prostate cancer) and MARS 2 (comparing extended pleurectomy decortication versus no extended pleurectomy decortication for patients with malignant pleural mesothelioma).